Division | P.I. | Sponsor | Title |
---|---|---|---|
Endocrinology | Tollefsen | Genentech, Inc. | PMS II Study |
Dermatology | Siegfried | Amgen | Evaluate Safety of Etanercept in Pediatric Patients with Plaque Psoriasis |
Pulmonary | Noyes | Seattle Children's Hospital | EPIC Observational Study |
Hematology | Ferguson | Fletcher Allen | Phase II Research Study of Nifurtimox |
Dermatology | Siegfried | Pierre Fabre | Infantile Hemangiomas Study |
Endocrinology | Tollefsen | Eli Lilly | The Genetics and Neuroendocrinology of Short Stature International Study |
Hematology | Puetz | Biogen Idec Inc. | An Open-Label, Multicenter Evaluation of Safety, BIIB031 |
Hematology | Ferguson | Van Andel Institute | NMRTC001 |
Hematology | Ferguson | University of Vermont | A Phase1 Trial of TPI 287 |
Genetics | Braddock | University of California San Diego | OTIS Autoimmune Diseases in Pregnancy Project |
Gastro | Teckman | Genentech, Inc. | A phase IIIb parallel group, open label study of pegylated interferon |
Pulmonary | Albers | Hologic | A Multi-Center Cystic Fibrosis Blood Sample Collection Study |
Pulmonary | Albers | Kalobios Pharmaceuticals | Study of KB001 A in Subjects with Cystic Fibrosis Infected with Pseudomonas aeruginosa |
Hematology | Ferguson | Children's Hospital of Philadelphia | COG industry Work Order |
Pulmonary | Albers | Gilead Sciences | Regimen of Inhaled Antibiotics for the Treatment of Chronic Pulmonary Pseudomonas in Subjects with Cystic Fibrosis |
Hematology | Ferguson | Children's Hospital of Philadelphia | A Phase I/II Trial of TPI 287 in Patients with Refractory or Recurrent Neuroblastoma or Medulloblastoma NMTRC004 |
Allergy | Knutsen | Baxter Healthcare Corp | Safety, Tolerability, and Pharmacokinetics in Subjects with Primary Immunodeficiency Diseases |
Hematology | Puetz | Biogen Idec Inc. | Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia A |
Hematology | Ferguson | Janssen Research Foundation | Abciximab (ReoProR) as a Therapeutic Intervention for Sickle Cell Vaso-Occlusive Pain Crisis |
Hematology | Ferguson | Spectrum Health Hospitals | NMTRC 008 A Feasibility Trial using Molecular-Guided Therapy for the Treatment of Patients |
Hematology | Ferguson | Eli Lilly | Prasugrel and Placebo in Pediatric Patients with Sickle Cell Disease |
Hematology | Ferguson | Van Andel Institute | Neuroblastoma in Remission - Protocol Number NMTRC 003 |
Pulmonary | Albers | Novartis Pharmaceuticals | Tobramycin Inhalation Powder (TIP) administered once daily in patients with cystic fibrosis |
Hematology | Puetz | American Thrombosis and Hemostasis Network | My Life, Our Future: A Hemophilia Genotyping Initiative Data and Sample Registry Repository |
Hematology | Ferguson | Children's Hospital of Philadelphia | COG Industry Work Order: FP17305 SUB102 02 GLENNON SANOFI AALL1131 WO |
Gastro | Teckman | Alnylam - Alpha 1 | Natural History Study |
Gastro | Teckman | Gilead Sciences | Gilead US 334-1112 |
Hematology | Ferguson | Van Andel Institute | NMTRC 009 Molecular Guided therapy for the treatment of refractory cancers |
Hematology | Puetz | Biogen Idec Inc. | Biogen 998HB303 |
Endocrinology | Siska | Novo Nordisk | Novo Nordisk - NN2211-3659 Ellipse |
Allergy | Knutsen | Hoffman LaRoche | Acoustics - WB28182 |
Endocrinology | Myers | Zafgen | Zafgen ZAF 311 Trial of ZGN 440 Beloranib |
Gastro | Teckman | Gilead Sciences | Gilead US 334-1116 Ledipasvir/Sofosbuvir tx for Hep C in Children |
Hematology | Puetz | Biogen Idec Inc. | PUP Hemophilia A |